Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.900 | 0.889 | 18 | 2009 | 2020 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms | 0.880 | 1.000 | 11 | 2009 | 2016 | |||||||
|
0.667 | 0.560 | 5 | 1288432 | intron variant | T/A;C | snv |
|
Neoplasms | 0.840 | 1.000 | 6 | 2009 | 2017 | ||||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Respiratory Tract Diseases | 0.840 | 1.000 | 4 | 2008 | 2019 | |||||||
|
0.724 | 0.240 | 5 | 1287079 | 3 prime UTR variant | G/A | snv | 0.63 |
|
Neoplasms | 0.810 | 1.000 | 3 | 2012 | 2016 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Respiratory Tract Diseases | 0.810 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Respiratory Tract Diseases | 0.800 | 1.000 | 20 | 2010 | 2015 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Respiratory Tract Diseases | 0.800 | 1.000 | 19 | 2010 | 2015 | |||||||
|
0.882 | 0.120 | 5 | 1294282 | missense variant | C/T | snv | 3.2E-04 | 1.8E-04 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||
|
0.882 | 0.120 | 5 | 1279341 | missense variant | C/T | snv | 7.0E-06 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | ||||||||
|
0.925 | 0.120 | 5 | 1272252 | missense variant | T/C | snv |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||||
|
0.882 | 0.160 | 5 | 1266524 | missense variant | C/T | snv | 8.2E-06 | 7.0E-06 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Nervous System Diseases | 0.800 | 1.000 | 5 | 2009 | 2014 | |||||||
|
1.000 | 5 | 1278781 | missense variant | C/T | snv |
|
0.800 | 1.000 | 5 | 2005 | 2012 | ||||||||||
|
1.000 | 5 | 1264542 | missense variant | T/C | snv |
|
0.800 | 1.000 | 5 | 2005 | 2012 | ||||||||||
|
1.000 | 5 | 1264479 | missense variant | G/A | snv | 4.0E-06 |
|
0.800 | 1.000 | 5 | 2005 | 2012 | |||||||||
|
0.925 | 0.120 | 5 | 1264541 | missense variant | C/G | snv | 4.0E-06 |
|
0.800 | 1.000 | 3 | 2005 | 2011 | ||||||||
|
0.550 | 0.880 | 5 | 1286401 | 3 prime UTR variant | C/A | snv | 0.52 |
|
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases | 0.800 | 1.000 | 3 | 2013 | 2017 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 2 | 2013 | 2019 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.750 | 1.000 | 11 | 2011 | 2019 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.750 | 1.000 | 8 | 2011 | 2019 | |||||||
|
0.649 | 0.320 | 5 | 1295234 | upstream gene variant | A/G | snv | 0.25 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.740 | 0.800 | 5 | 2016 | 2018 | |||||||
|
0.724 | 0.240 | 5 | 1287079 | 3 prime UTR variant | G/A | snv | 0.63 |
|
Neoplasms; Respiratory Tract Diseases | 0.740 | 1.000 | 4 | 2016 | 2019 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Endocrine System Diseases | 0.720 | 1.000 | 3 | 2016 | 2019 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms | 0.710 | 1.000 | 3 | 2015 | 2018 |